Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.

Ritchie CW, Khandker RK, Pike J, Black CM, Jones E, Ambegaonkar BM.

J Alzheimers Dis. 2018;64(3):899-910. doi: 10.3233/JAD-180306.

PMID:
29966202
2.

Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's Disease.

Khandker RK, Black CM, Xie L, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Fillit H.

J Am Geriatr Soc. 2018 May;66(5):864-870. doi: 10.1111/jgs.15281. Epub 2018 Mar 30.

PMID:
29601083
3.

Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries.

Ritchie CW, Black CM, Khandker RK, Wood R, Jones E, Hu X, Ambegaonkar BM.

J Alzheimers Dis. 2018;62(1):457-466. doi: 10.3233/JAD-170864.

PMID:
29439347
4.

Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.

Black CM, Fillit H, Xie L, Hu X, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Khandker RK.

J Alzheimers Dis. 2018;61(1):185-193. doi: 10.3233/JAD-170518.

PMID:
29103033
5.

Association between low muscle mass, functional limitations and hospitalisation in heart failure: NHANES 1999-2004.

DiBello JR, Miller R, Khandker R, Bourgeois N, Galwey N, Clark RV.

Age Ageing. 2015 Nov;44(6):948-54. doi: 10.1093/ageing/afv129. Epub 2015 Sep 22.

PMID:
26396183
6.

Impact of rheumatoid arthritis on quality of life, work productivity and resource utilisation: an observational, cross-sectional study in Brazil.

da Rocha Castelar Pinheiro G, Khandker RK, Sato R, Rose A, Piercy J.

Clin Exp Rheumatol. 2013 May-Jun;31(3):334-40. Epub 2013 Jan 16.

PMID:
23324808
7.

Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.

Bae SC, Gun SC, Mok CC, Khandker R, Nab HW, Koenig AS, Vlahos B, Pedersen R, Singh A.

BMC Musculoskelet Disord. 2013 Jan 8;14:13. doi: 10.1186/1471-2474-14-13.

8.

Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial.

Kim HY, Hsu PN, Barba M, Sulaiman W, Robertson D, Vlahos B, Khandker R, Nab H, Freundlich B, Koenig A.

Int J Rheum Dis. 2012 Apr;15(2):188-96. doi: 10.1111/j.1756-185X.2011.01680.x. Epub 2011 Oct 28.

PMID:
22462423
9.

Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.

Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A.

Rheumatology (Oxford). 2011 Feb;50(2):401-9. doi: 10.1093/rheumatology/keq327. Epub 2010 Nov 8.

PMID:
21059675
10.

The impact of uncontrolled asthma on absenteeism and health-related quality of life.

Dean BB, Calimlim BM, Kindermann SL, Khandker RK, Tinkelman D.

J Asthma. 2009 Nov;46(9):861-6. doi: 10.3109/02770900903184237.

PMID:
19905909
11.

Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.

Joyce AT, Smith P, Khandker R, Melin JM, Singh A.

J Rheumatol. 2009 Apr;36(4):743-52. doi: 10.3899/jrheum.080670. Epub 2009 Feb 17.

PMID:
19228658
12.

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Khandker R, Singh A, Wajdula J, Fatenejad S; Etanercept European Investigators Network.

Ann Rheum Dis. 2009 Jul;68(7):1146-52. doi: 10.1136/ard.2007.087106. Epub 2008 Sep 15.

13.

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, Fatenejad S.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):948-55. doi: 10.1164/rccm.200709-1446OC. Epub 2008 Jul 31.

PMID:
18669816
14.
15.

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.

Sobocki P, Ekman M, Ovanfors A, Khandker R, Jönsson B.

Int J Clin Pract. 2008 Apr;62(4):623-32. doi: 10.1111/j.1742-1241.2008.01711.x. Epub 2008 Feb 15.

16.

Recovery from depression predicts lower health services costs.

Simon GE, Khandker RK, Ichikawa L, Operskalski BH.

J Clin Psychiatry. 2006 Aug;67(8):1226-31.

PMID:
16965200
17.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
18.

A one-year comparison of cost and outcomes of angioplasty in stent and nonstent patients.

Sen SS, Khandker RK, Roth DA, Thomas J 3rd.

Am J Ther. 2005 May-Jun;12(3):210-7.

PMID:
15891263
19.
20.

A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults.

Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB.

Int J Technol Assess Health Care. 2000 Summer;16(3):799-810.

PMID:
11028135
21.

Medicare spending by beneficiaries with various types of supplemental insurance.

Khandker RK, McCormack LA.

Med Care Res Rev. 1999 Jun;56(2):137-55.

PMID:
10373721
22.
23.

Impact of Medicare SELECT on cost and utilization in 11 states.

Lee AJ, Garfinkel SA, Khandker RK, Norton EC.

Health Care Financ Rev. 1997 Fall;19(1):19-40.

24.

Evaluating Alternative Risk Adjusters for Medicare.

Pope GC, Adamache KW, Walsh EG, Khandker RK.

Health Care Financ Rev. 1998 Winter;20(2):109-129.

25.

Programmatic, economic, and demographic forces underlying Medicaid enrollment trends.

Cromwell J, Adamache KW, Khandker RK, Ammering C.

Med Care Res Rev. 1997 Jun;54(2):150-75. Review. No abstract available.

PMID:
9437163
26.

Black-white treatment differences in acute myocardial infarction.

Mitchell JB, Khandker RK.

Health Care Financ Rev. 1995 Winter;17(2):61-70.

27.

Variations in Medicare access and satisfaction by health status: 1991-93.

Rosenbach ML, Acamache KW, Khandker RK.

Health Care Financ Rev. 1995 Winter;17(2):29-49.

28.

Utilization review savings at the micro level.

Khandker RK, Manning WG, Ahmed T.

Med Care. 1992 Nov;30(11):1043-52.

PMID:
1434957
29.

The impact of utilization review on costs and utilization.

Khandker RK, Manning WG.

Dev Health Econ Public Policy. 1992;1:47-62.

PMID:
10151753
30.

Sigmoid kinetics of the monomeric ribonuclease I due to ligand-induced shifts of conformation equilibria.

Rübsamen H, Khandker R, Witzel H.

Hoppe Seylers Z Physiol Chem. 1974 Jun;355(6):687-708. No abstract available.

PMID:
4474133
31.

[Sigmoidal kinetics in monomeric pancreas ribonuclease on the basis of an equilibrium between two enzyme species of varying activity].

Rübsamen H, Khandker R, Witzel H.

Hoppe Seylers Z Physiol Chem. 1972 May;353(5):749-50. German. No abstract available.

PMID:
5069319

Supplemental Content

Loading ...
Support Center